vs
Acadia Healthcare Company, Inc.(ACHC)与Astrana Health, Inc.(ASTH)财务数据对比。点击上方公司名可切换其他公司
Astrana Health, Inc.的季度营收约是Acadia Healthcare Company, Inc.的1.1倍($950.5M vs $829.0M),Astrana Health, Inc.净利率更高(0.7% vs 0.5%,领先0.2%),Astrana Health, Inc.同比增速更快(42.9% vs 7.5%),过去两年Astrana Health, Inc.的营收复合增速更高(53.3% vs 2.0%)
阿卡迪亚医疗公司是美国的营利性行为医疗健康服务提供商,目前在美国及波多黎各地区运营着超过225家医疗机构,搭建了覆盖广泛的行为健康服务网络,为有相关需求的人群提供专业的心理健康与行为干预服务。
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商,主要服务全美符合联邦医保资格的老年群体,提供上门初级护理、慢性病管理及护理协调服务,致力于提升患者健康水平、降低不必要的医疗支出。
ACHC vs ASTH — 直观对比
营收规模更大
ASTH
是对方的1.1倍
$829.0M
营收增速更快
ASTH
高出35.4%
7.5%
净利率更高
ASTH
高出0.2%
0.5%
两年增速更快
ASTH
近两年复合增速
2.0%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $829.0M | $950.5M |
| 净利润 | $4.5M | $6.6M |
| 毛利率 | — | — |
| 营业利润率 | — | 1.9% |
| 净利率 | 0.5% | 0.7% |
| 营收同比 | 7.5% | 42.9% |
| 净利润同比 | -50.8% | 184.4% |
| 每股收益(稀释后) | $0.05 | $0.12 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ACHC
ASTH
| Q1 26 | $829.0M | — | ||
| Q4 25 | $821.5M | $950.5M | ||
| Q3 25 | $851.6M | $956.0M | ||
| Q2 25 | $869.2M | $654.8M | ||
| Q1 25 | $770.5M | $620.4M | ||
| Q4 24 | $774.2M | $665.2M | ||
| Q3 24 | $815.6M | $478.7M | ||
| Q2 24 | $796.0M | $486.3M |
净利润
ACHC
ASTH
| Q1 26 | $4.5M | — | ||
| Q4 25 | $-1.2B | $6.6M | ||
| Q3 25 | $36.2M | $373.0K | ||
| Q2 25 | $30.1M | $9.4M | ||
| Q1 25 | $8.4M | $6.7M | ||
| Q4 24 | $32.6M | $-7.8M | ||
| Q3 24 | $68.1M | $16.1M | ||
| Q2 24 | $78.5M | $19.2M |
营业利润率
ACHC
ASTH
| Q1 26 | — | — | ||
| Q4 25 | -142.4% | 1.9% | ||
| Q3 25 | 4.7% | 2.0% | ||
| Q2 25 | 5.8% | 3.1% | ||
| Q1 25 | 1.7% | 3.3% | ||
| Q4 24 | 4.9% | 0.1% | ||
| Q3 24 | 12.1% | 5.9% | ||
| Q2 24 | 13.4% | 6.2% |
净利率
ACHC
ASTH
| Q1 26 | 0.5% | — | ||
| Q4 25 | -143.3% | 0.7% | ||
| Q3 25 | 4.3% | 0.0% | ||
| Q2 25 | 3.5% | 1.4% | ||
| Q1 25 | 1.1% | 1.1% | ||
| Q4 24 | 4.2% | -1.2% | ||
| Q3 24 | 8.4% | 3.4% | ||
| Q2 24 | 9.9% | 3.9% |
每股收益(稀释后)
ACHC
ASTH
| Q1 26 | $0.05 | — | ||
| Q4 25 | $-12.98 | $0.12 | ||
| Q3 25 | $0.40 | $0.01 | ||
| Q2 25 | $0.33 | $0.19 | ||
| Q1 25 | $0.09 | $0.14 | ||
| Q4 24 | $0.36 | $-0.14 | ||
| Q3 24 | $0.74 | $0.33 | ||
| Q2 24 | $0.85 | $0.40 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $158.5M | $429.5M |
| 总债务越低越好 | $2.5B | — |
| 股东权益账面价值 | $2.0B | $779.3M |
| 总资产 | $5.5B | $2.2B |
| 负债/权益比越低杠杆越低 | 1.29× | — |
8季度趋势,按日历期对齐
现金及短期投资
ACHC
ASTH
| Q1 26 | $158.5M | — | ||
| Q4 25 | $133.2M | $429.5M | ||
| Q3 25 | $118.7M | $463.4M | ||
| Q2 25 | $131.4M | $342.1M | ||
| Q1 25 | $91.2M | $260.9M | ||
| Q4 24 | $76.3M | $290.8M | ||
| Q3 24 | $82.1M | $350.3M | ||
| Q2 24 | $77.2M | $327.7M |
总债务
ACHC
ASTH
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.3B | — | ||
| Q2 25 | $2.3B | — | ||
| Q1 25 | $2.2B | — | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $1.9B | — | ||
| Q2 24 | $1.8B | — |
股东权益
ACHC
ASTH
| Q1 26 | $2.0B | — | ||
| Q4 25 | $1.9B | $779.3M | ||
| Q3 25 | $3.1B | $775.5M | ||
| Q2 25 | $3.1B | $765.5M | ||
| Q1 25 | $3.0B | $745.4M | ||
| Q4 24 | $3.1B | $712.7M | ||
| Q3 24 | $3.0B | $704.6M | ||
| Q2 24 | $3.0B | $678.9M |
总资产
ACHC
ASTH
| Q1 26 | $5.5B | — | ||
| Q4 25 | $5.5B | $2.2B | ||
| Q3 25 | $6.4B | $2.2B | ||
| Q2 25 | $6.3B | $1.4B | ||
| Q1 25 | $6.1B | $1.3B | ||
| Q4 24 | $6.0B | $1.4B | ||
| Q3 24 | $5.9B | $1.3B | ||
| Q2 24 | $5.7B | $1.3B |
负债/权益比
ACHC
ASTH
| Q1 26 | 1.29× | — | ||
| Q4 25 | 1.28× | — | ||
| Q3 25 | 0.74× | — | ||
| Q2 25 | 0.74× | — | ||
| Q1 25 | 0.72× | — | ||
| Q4 24 | 0.64× | — | ||
| Q3 24 | 0.62× | — | ||
| Q2 24 | 0.62× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $61.5M | $-2.9M |
| 自由现金流经营现金流 - 资本支出 | — | $-6.0M |
| 自由现金流率自由现金流/营收 | — | -0.6% |
| 资本支出强度资本支出/营收 | — | 0.3% |
| 现金转化率经营现金流/净利润 | 13.78× | -0.44× |
| 过去12个月自由现金流最近4个季度 | — | $104.5M |
8季度趋势,按日历期对齐
经营现金流
ACHC
ASTH
| Q1 26 | $61.5M | — | ||
| Q4 25 | $-86.3M | $-2.9M | ||
| Q3 25 | $73.2M | $10.0M | ||
| Q2 25 | $133.5M | $90.9M | ||
| Q1 25 | $11.5M | $16.6M | ||
| Q4 24 | $116.7M | $-10.9M | ||
| Q3 24 | $163.1M | $34.0M | ||
| Q2 24 | $171.1M | $23.2M |
自由现金流
ACHC
ASTH
| Q1 26 | — | — | ||
| Q4 25 | $-179.5M | $-6.0M | ||
| Q3 25 | $-63.0M | $7.4M | ||
| Q2 25 | $-34.2M | $89.5M | ||
| Q1 25 | $-163.2M | $13.6M | ||
| Q4 24 | $-86.8M | $-13.5M | ||
| Q3 24 | $-27.1M | $31.7M | ||
| Q2 24 | $16.9M | $20.4M |
自由现金流率
ACHC
ASTH
| Q1 26 | — | — | ||
| Q4 25 | -21.8% | -0.6% | ||
| Q3 25 | -7.4% | 0.8% | ||
| Q2 25 | -3.9% | 13.7% | ||
| Q1 25 | -21.2% | 2.2% | ||
| Q4 24 | -11.2% | -2.0% | ||
| Q3 24 | -3.3% | 6.6% | ||
| Q2 24 | 2.1% | 4.2% |
资本支出强度
ACHC
ASTH
| Q1 26 | — | — | ||
| Q4 25 | 11.3% | 0.3% | ||
| Q3 25 | 16.0% | 0.3% | ||
| Q2 25 | 19.3% | 0.2% | ||
| Q1 25 | 22.7% | 0.5% | ||
| Q4 24 | 26.3% | 0.4% | ||
| Q3 24 | 23.3% | 0.5% | ||
| Q2 24 | 19.4% | 0.6% |
现金转化率
ACHC
ASTH
| Q1 26 | 13.78× | — | ||
| Q4 25 | — | -0.44× | ||
| Q3 25 | 2.02× | 26.69× | ||
| Q2 25 | 4.43× | 9.65× | ||
| Q1 25 | 1.37× | 2.48× | ||
| Q4 24 | 3.58× | — | ||
| Q3 24 | 2.39× | 2.11× | ||
| Q2 24 | 2.18× | 1.21× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |